Feasibility and Safety of Single-Probe Cryoablation with Liquid Nitrogen: An Initial Experience in 24 Various Tumor Lesions
The aim of this retrospective study was to assess the feasibility of the IceCure’s single-probe liquid nitrogen system for tumor lesions of various sizes and locations, and to evaluate the safety of cryoablation with this technique.
This retrospective observational study conducted by Professor Hiroaki Nomori, MD found that cryoablation using liquid nitrogen would be one of the treatment methods for metastatic lung cancers <2.2 cm; and pulmonary function decreased significantly when cryoablation was performed for an increasing number of tumors.
Radiation following cryoablation for low risk breast tumors: assessment of safety and variables that effect referral
Poster presented at the 2021 San Antonio Breast Cancer Symposium that examined treatment decisions regarding radiation referral of physicians in the ICE3 trial on cryoablation of small, low-risk breast cancers and evaluated the safety of the combined modalities in this population.
VAB and MRI Following Percutaneous Ultra-Sound Guided Cryoablation for Primary Early-Stage Breast Cancer: A Pilot Study in Japan
This study’s purpose was to evaluate the safety, feasibility, and cosmetic outcomes of cryoablation of breast IDC lesions and evaluate post-cryoablation MRI as a follow up tool for detection of residual malignancies and local recurrences. Study authors concluded that cryoablation of early-stage low-risk breast cancer tumors small than 15cm can be a potential substitute for lumpectomy.
Cryoablation Without Excision for Low-Risk Early-Stage Breast Cancer: 3-Year Interim Analysis of Ipsilateral Breast Tumor Recurrence in the ICE3 Trial
Interim analysis of the ICE3 Clinical Trial on Cryoablation of Small, Low-Risk Breast Cancer as published in the Annals of Surgical Oncology by Dr. Richard E. Fine as the lead author.
This article outlines breast cancer cryoablation treatment, describes proper patient selection and techniques, and presents 2 cases that illustrate mammographic findings post treatment with cryoablation as part of the ICE3 clinical trial.
Cryoablation Without Excision for Early-Stage Breast Cancer; ICE3 Trial Update on Ipsilateral Breast Tumor Recurrence (ASBRS)
Scientific Oral Presentation from ASBrS 2021. Of 194 eligible patients were treated with cryoablation, at a mean of 34.83 months (about 3 years) following treatment with the ProSense™ Cryoablation System, only 2.06% (4 patients) experienced cancer recurrence.
This study was aimed at evaluating the efficiency of cryoablation using liquid nitrogen in lung tissue by measuring the size and temperature distribution of the frozen area (ice ball) in gel and in the ex vivo pig lungs.
This study focused on evaluating local control and complications of cryoablation for T1N0M0 non-small cell lung cancer using liquid nitrogen.
This study evaluated cryoablation under ultrasound guidance in the office setting with liquid nitrogen system for patients with fibroadenoma.